https://scholars.lib.ntu.edu.tw/handle/123456789/346434
標題: | Characterization of Escherichia coli nitroreductase NfsB in the metabolism of nitrobenzodiazepines | 作者: | Wu, Shiuan-Woei Lin FU-CHUO PENG Syu, Cheng-Jie Chen, Yu-Lian Wang, Andrew H.-J. Peng, Fu-Chuo |
關鍵字: | Escherichia coli nitroreductase NfsB; Flunitrazepam; NADPH-cytochrome P450 reductase; Nitrobenzodiazepine; Rat jejunal microflora | 公開日期: | 2009 | 卷: | 78 | 期: | 1 | 起(迄)頁: | 96-103 | 來源出版物: | Biochemical Pharmacology | 摘要: | Nitrobenzodiazepine (NBDZ) is a sedative-hypnotic drug used in the treatment of anxiety and sleep problems. Overdose of NBDZ may cause severe neurological effects, especially for people in drug abuse or addiction. In the present study, we investigated NBDZ nitroreduction in rat enteric contents and characterized the role of enterobacterial nitroreductase in the reductive pathway. Nitroreduction of flunitrazepam (FZ) was studied in the microsomal membrane fractions of rat liver, jejunum and jejunal microflora using HPLC analysis. In the jejunal microflora, FZ was demonstrated to be significantly reduced to its amino derivative under anaerobic condition. Escherichia coli type I nitroreductase NfsB (EC 1.5.1.34) was found in rat jejunal microflora via PCR technique and Western blotting. The participation of NfsB in FZ nitroreduction was demonstrated from inhibition studies. Kinetic study of the purified recombinant NfsB indicated that nitroreduction of FZ, nitrazepam (NZ) and clonazepam (CZ) are mediated by NfsB, where CZ shows lower kcat/KM ratio than that of the other two. Finally, two other nitroreductases E. cloacae NR (EC 1.6.99.7) and S. typhimurium Cnr were also found to be responsible for FZ nitroreduction. These results provide that the reduction of NBDZ in normal flora is catalyzed by type I nitroreductase NfsB. ? 2009 Elsevier Inc. All rights reserved. |
URI: | http://www.scopus.com/inward/record.url?eid=2-s2.0-67349129059&partnerID=MN8TOARS http://scholars.lib.ntu.edu.tw/handle/123456789/346434 |
DOI: | 10.1016/j.bcp.2009.03.019 | SDG/關鍵字: | 7 aminobenzodiazepine; benzodiazepine derivative; clonazepam; flunitrazepam; nitrazepam; nitrobenzodiazepine; nitroreductase; nitroreductase NfsB; unclassified drug; animal tissue; article; controlled study; drug metabolism; drug structure; Enterobacter cloacae; Enterobacteriaceae; enzyme inhibition; enzyme kinetics; Escherichia coli; high performance liquid chromatography; jejunum; liver microsome; nonhuman; polyacrylamide gel electrophoresis; polymerase chain reaction; priority journal; protein expression; protein purification; rat; reduction; Salmonella typhimurium; statistical analysis; Western blotting; Animals; Benzodiazepines; Biotransformation; Escherichia coli; Escherichia coli Proteins; Flunitrazepam; Intracellular Membranes; Jejunum; Male; Microsomes; Microsomes, Liver; Nitro Compounds; Nitroreductases; Oxidation-Reduction; Rats; Rats, Wistar; Salmonella typhimurium |
顯示於: | 毒理學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。